Based on the initial bone marrow and renal biopsy findings, our patient was initially treated for AL amyloidosis with chemotherapy, which has no role and can be harmful in hereditary amyloidosis in general, including apolipoprotein C-II-associated disease [4–6]. The gene discussed is APOC2; the disease is hereditary amyloidosis.